Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Aberrant Cerebral Blood Flow in Response to Hunger and Satiety in Women Remitted from Anorexia Nervosa.

Wierenga CE, Bischoff-Grethe A, Rasmusson G, Bailer UF, Berner LA, Liu TT, Kaye WH.

Front Nutr. 2017 Jul 19;4:32. doi: 10.3389/fnut.2017.00032. eCollection 2017.

2.

Differences in body structure and function between patients with systemic lupus erythematosus and healthy individuals, with particular reference to joint hypermobility.

Johnsson PM, Kohlin C, Rasmusson GR, Bengtsson AA, Sturfelt G, Nived O.

Scand J Rheumatol. 2017 Jan;46(1):40-43. doi: 10.3109/03009742.2016.1158313. Epub 2016 May 12.

PMID:
27172144
3.

MK386: a potent, selective inhibitor of the human type 1 5alpha-reductase.

Ellsworth K, Azzolina B, Baginsky W, Bull H, Chang B, Cimis G, Mitra S, Toney J, Bakshi RK, Rasmusson GR, Tolman RL, Harris GS.

J Steroid Biochem Mol Biol. 1996 Jul;58(4):377-84.

PMID:
8903421
4.

Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.

Huskey SW, Dean DC, Miller RR, Rasmusson GH, Chiu SH.

Drug Metab Dispos. 1995 Oct;23(10):1126-35. Erratum in: Drug Metab Dispos 1996 Jun;24(6):695.

PMID:
8654202
5.

4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.

Bakshi RK, Rasmusson GH, Patel GF, Mosley RT, Chang B, Ellsworth K, Harris GS, Tolman RL.

J Med Chem. 1995 Aug 18;38(17):3189-92. No abstract available.

PMID:
7650670
6.

Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.

Cohen SM, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM.

Prostate. 1995 Feb;26(2):55-71.

PMID:
7531846
7.

4,7 beta-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human type 1 5 alpha-reductase.

Bakshi RK, Patel GF, Rasmusson GH, Baginsky WF, Cimis G, Ellsworth K, Chang B, Bull H, Tolman RL, Harris GS.

J Med Chem. 1994 Nov 11;37(23):3871-4. No abstract available.

PMID:
7966146
8.

Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin.

Mellin TN, Busch RD, Rasmusson GH.

J Steroid Biochem Mol Biol. 1993 Feb;44(2):121-31.

PMID:
8439517
9.

Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp.

Harris G, Azzolina B, Baginsky W, Cimis G, Rasmusson GH, Tolman RL, Raetz CR, Ellsworth K.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10787-91.

10.

Topical anti-androgenicity of a new 4-azasteroid in the hamster.

Brooks JR, Primka RL, Berman C, Krupa DA, Reynolds GF, Rasmusson GH.

Steroids. 1991 Aug;56(8):428-33.

PMID:
1788861
11.

Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.

Brooks JR, Berman C, Nguyen H, Prahalada S, Primka RL, Rasmusson GH, Slater EE.

Prostate. 1991;18(3):215-27.

PMID:
1850515
12.

Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.

Rasmusson GH, Reynolds GF, Steinberg NG, Walton E, Patel GF, Liang T, Cascieri MA, Cheung AH, Brooks JR, Berman C.

J Med Chem. 1986 Nov;29(11):2298-315.

PMID:
3783591
13.

5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat.

Brooks JR, Berman C, Primka RL, Reynolds GF, Rasmusson GH.

Steroids. 1986 Jan;47(1):1-19.

PMID:
3810695
14.

Prostatic effects induced in dogs by chronic or acute oral administration of 5 alpha-reductase inhibitors.

Brooks JR, Berman C, Garnes D, Giltinan D, Gordon LR, Malatesta PF, Primka RL, Reynolds GF, Rasmusson GH.

Prostate. 1986;9(1):65-75.

PMID:
3737486
15.

Selenium dioxide oxidation of vitamin D3 acetate to a dimer of 1-oxotransvitamin D3 acetate.

Reynolds GF, Reamer RA, Rasmusson GH.

Steroids. 1985 Oct-Nov;46(4-5):883-7.

PMID:
3018968
16.

Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.

Liang T, Cascieri MA, Cheung AH, Reynolds GF, Rasmusson GH.

Endocrinology. 1985 Aug;117(2):571-9.

PMID:
4017948
17.

Photoaffinity labeling of steroid 5 alpha-reductase of rat liver and prostate microsomes.

Liang T, Cheung AH, Reynolds GF, Rasmusson GH.

J Biol Chem. 1985 Apr 25;260(8):4890-5.

18.

Azasteroids as inhibitors of rat prostatic 5 alpha-reductase.

Rasmusson GH, Reynolds GF, Utne T, Jobson RB, Primka RL, Berman C, Brooks JR.

J Med Chem. 1984 Dec;27(12):1690-701.

PMID:
6502599
19.

4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.

Liang T, Heiss CE, Cheung AH, Reynolds GF, Rasmusson GH.

J Biol Chem. 1984 Jan 25;259(2):734-9.

20.

Supplemental Content

Loading ...
Support Center